RESUMEN
PURPOSE: To determine the causes of low vision among Sudanese patients with diabetic retinopathy (DR) by using ophthalmic B-scan ultrasonography. MATERIALS AND METHODS: A total of 100 patients with DR at different grades, were recruited prospectively between September 2016 and January 2018. Nidek (Echoscan US-4000) ultrasound unit was used to determine the causes of low vision in diabetic patients according to their glycated haemoglobin (HbA1c) and early treatment of diabetic retinopathy scale (ETDRS) severity levels. RESULTS: Vitreous hemorrhage (VH) 42(66.6%), asteroid hyalosis (AH) 12(14.3%), and partial retinal detachment (PRD) 9(19%) were the main cause of low vision in patients presenting with moderately regulated HbA1c and graded with either minimal or mild nonproliferative retinopathy (NPDR). While VH 15(40.5%), total retinal detachment (TRD) 12(32.4%), posterior vitreous detachment (PVD) 7(19%), and choroidal detachment (CD) 3(8.1%), were dominant in patients with poorly regulated HbA1c and graded either as moderate NPDR; severe NPDR; and proliferative retinopathy (PR). CONCLUSIONS: Ophthalmic B-mode ultrasound is a rapid, noninvasive imaging technique that can be used with minimum discomfort in ophthalmological practice for the detection and evaluation of DR complications that predict the visual outcome.
RESUMEN
BACKGROUND/AIMS: p53 gene mutation occurs in about 50-60% of colorectal carcinoma cases. This mostly occurs as a late event in the adenoma-carcinoma sequence. These late stages are associated with more aneuploidy compared to adenomas and early carcinomas. However there is a controversy regarding the relation between p53 overexpression and DNA index. This study was designed to investigate the relationship between p53 status and DNA ploidy pattern. METHODOLOGY: Nuclear DNA content of paraffin-embedded material from 83 colectomy specimens for colorectal carcinoma was measured by flow cytometry. Also, p53 was detected by immunohistochemistry in 73 out of the 83 tumor cases using a monoclonal antibody that detects both wild and mutant p53 proteins (Biogenex 1801). RESULTS: Aneuploidy was identified in 37 cases (46.25%). Tumors with rectal location were significantly more aneuploid in comparison to other sites (P = 0.009), p53 staining showed three patterns: diffuse staining (29 cases), focal (13 cases), and negative (31 cases). Diffuse p53 staining was associated with aneuploidy (P = 0.04). The majority of DNA indices fell within the range 1.1-2.2 (32 out of 37). Twenty-one of these had DNA index = 1.1-1.8 (aneuploidy short of tetraploidy) significantly associated with diffuse p53 staining compared with peritetraploid cases (DNA index 1.8-2.2) (P = 0.034). CONCLUSIONS: p53 immunohistochemistry demonstrates two distinct patterns in colorectal carcinoma. Diffuse p53 staining, which is associated with aneuploidy short of tetraploidy (DNA index 1.1-1.8), a finding which is different from previously published work. Focal p53 staining pattern, in contrast, is related to high G2M and more abnormal tetraploid peaks but less aneuploidy.